The 20th Asia Pacific Congress of Clinical Microbiology and Infection (APCCMI2025) will remain in our collective memories. We are filled with a sense of gratitude, inspiration, and immense pride. Over these congress days we have witnessed an extraordinary convergence of minds that will shape the future of clinical microbiology and infection and, by extension, our world.
First and foremost, we would like to extend our heartfelt thanks to our distinguished speakers whose groundbreaking research and thought-provoking presentations have been the cornerstone of this congress. We had lively poster sessions and oral presentations. Your contributions have sparked vigorous discussions, fostered collaborations, and opened new avenues of inquiry.
To our sponsors and partners, your generous support has been instrumental in making this event a success. Your commitment to advancing the field of clinical microbiology and infection and supporting scientific endeavors is deeply appreciated.
To the organizing committee, the scientific committee and the organizer who have worked tirelessly behind the scenes, this event would not have been possible without your dedication and hard work.
Thank you to all our delegates from across Asia Pacific and around the world for making this event such a success! The insights and connections made during the congress are invaluable.
We look forward to seeing you at the APCCMI2027 in Nagasaki.
APCCMI 2025 Report
APCCMI 2025 in Bangkok, Thailand at True IconHall was highly successful with a total of 1,504 participants from 49 countries and 34 sponsors/exhibitors.
Countries
The 1,504 participants were from the following countries:
| Country | Total | |
|---|---|---|
| 1 | Argentina | 1 |
| 2 | Armenia | 1 |
| 3 | Australia | 37 |
| 4 | Bangladesh | 2 |
| 5 | Belgium | 2 |
| 6 | Bosnia and Herzegovina | 1 |
| 7 | Brunei Darussalam | 4 |
| 8 | Canada | 4 |
| 9 | China | 33 |
| 10 | Croatia | 1 |
| 11 | France | 2 |
| 12 | Georgia | 3 |
| 13 | Germany | 2 |
| 14 | Ghana | 1 |
| 15 | Hong Kong | 14 |
| 16 | India | 28 |
| 17 | Indonesia | 28 |
| Country | Total | |
|---|---|---|
| 18 | Ireland | 2 |
| 19 | Israel | 5 |
| 20 | Japan | 106 |
| 21 | Jordan | 1 |
| 22 | Kazakhstan | 2 |
| 23 | Korea | 59 |
| 24 | Kuwait | 1 |
| 25 | Laos | 4 |
| 26 | Lebanon | 1 |
| 27 | Malaysia | 66 |
| 28 | Mongolia | 3 |
| 29 | Morocco | 3 |
| 30 | Nepal | 4 |
| 31 | Netherlands | 3 |
| 32 | New Zealand | 3 |
| 33 | Pakistan | 12 |
| 34 | Peru | 1 |
| Country | Total | |
|---|---|---|
| 35 | Philippines | 82 |
| 36 | Poland | 2 |
| 37 | Qatar | 1 |
| 38 | Russia | 2 |
| 39 | Serbia and Montenegro | 1 |
| 40 | Singapore | 106 |
| 41 | Spain | 1 |
| 42 | Sri Lanka | 10 |
| 43 | Switzerland | 4 |
| 44 | Taiwan | 19 |
| 45 | Thailand | 729 |
| 46 | United Arab Emirates | 2 |
| 47 | United Kingdom | 10 |
| 48 | USA | 16 |
| 49 | Vietnam | 79 |
| Total | 1,504 |
Sessions and Presentations
A total of 59 sessions and one industrial exhibition were conducted as follows:
| Session Type | No. of Sessions | No. of Presentations | |
|---|---|---|---|
| 1 | Pre-Congress Workshops | 3 sessions | 20 |
| 2 | Keynote Sessions | 3 sessions | 3 |
| 3 | Plenary Sessions | 6 sessions | 6 |
| 4 | Concurrent Symposia | 16 sessions | 54 |
| 5 | Meet-the-Expert Sessions | 10 sessions | 16 |
| 6 | Industrial Lunch Symposia | 11 sessions | 11 |
| 7 | Oral Presentation Sessions | 6 sessions | 33 |
| 8 | Rapidfire | 4 sessions throughout 2 days | |
| 9 | E-poster Exhibition (3 days) | 1 exhibition throughout 3 days | |
| 10 | Abstract Presentations |
84 presentations comprising
|
|
| 11 | Industry Exhibition | 1 session throughout 3 days | |
| Total | 59 sessions | 184 presentations |
Invited Speakers
We proudly welcomed 104 esteemed invited speakers who shared their expertise through 184 insightful presentations.
Awards and Recognition
A total of 10 Travel Awards were conferred to the following persons:
| Full Name | Organization | Country | |
|---|---|---|---|
| 1 | Md Nannur Rahman | Mawlana Bhashani Science And Technology University | Bangladesh |
| 2 | Sylvester K. A. Newton | Kumasi Center for Collaborative Research in Tropical Medicine | Ghana |
| 3 | Pravinkumar Dudhagara | Veer Narmad South Gujarat University | India |
| 4 | Taru Singh | Amity University | India |
| 5 | Kamena M. Y. Hassan | Ibn Rochd University Hospital | Morocco |
| 6 | Candido Faiela | Eduardo Mondlane University | Mozambique |
| 7 | Jose Langa | Eduardo Mondlane University | Mozambique |
| 8 | Shreedhar Aryal | Tokha Chandeshwori Hospital | Nepal |
| 9 | Dristi Halwai | B.P Koirala Institute of Health Sciences | Nepal |
| 10 | Kuruppuge D. S. T. Abeywardana | Ministry of Health Sri Lanka | Sri Lanka |
Best Oral Presentation Winners
| Antimicrobial Agents & Resistance | |
|---|---|
| RES-364 | Efficacy and Safety in a Phase 2 study of intravenous BV100 combined with Polymyxin B versus Best Available Therapy in adult subjects with ventilator-associated bacterial pneumonia suspected or confirmed to be due to carbapenem resistant Acinetobacter bauDavid Paterson, Singapore |
| Antimicrobial Stewardship & Clinical Microbiology Diagnostics | |
| RES-338 | Comparison of DNA Extraction Protocols for Long-Read Sequencing of Clinical Pathogenic FungiThitima Suwannasaeng, Thailand |
| Clinical Infectious Diseases (Bacterial, Fungal, Mycobacterial, Parasitic) | |
| RES-356 | Tuberculosis treatment outcome among individuals with hematologic and solid malignancies in high TB burden setting.Sivaporn Gatechompol, Thailand |
| Viral Infections & Immunology | |
| RES-020 | Optimizing HIV Care in Thailand: Clinical Pharmacists' Role in Detecting and Reducing Medication Errors at a Single University HospitalKittiya Jantarathaneewat, Thailand |
| Healthcare Epidemiology & Infection Prevention/Control | |
| RES-083 | AISHIELD: Artificial Intelligence for Surveillance and Health Informatics through EMR-translating LLMs for infectious DiseasesAung Hein Aung, Singapore |
| Emerging Topics & Others | |
| RES-137 | Metagenomic profiles of blood-fed ticks in Asian countries using next-generation sequencingHye-ryung Byun, Korea |
Best Poster Winners
| Antimicrobial Agents & Resistance | |
|---|---|
| LB-RES-009 | Comparative Genomics to Investigate the Resistome and Bacterial Heterogeneity in the Creekside Ecosystem in Navotas City: An Exploratory ResearchMariae Janselle Pamposa, Philippines |
| RES-369 | Direct Antimicrobial Resistance Prediction from Surface-Enhanced Raman Scattering Spectra Using Artificial IntelligenceHao-Chieh Chiu, Taiwan |
| Antimicrobial Stewardship & Clinical Microbiology Diagnostics | |
| RES-197 | Deep Learning for Early Bacterial Colony Identification through Time-Lapse ImagingMiyuki Fujioka, Japan |
| RES-142 | The Implementation of Antimicrobial Consumption Surveillance and Stewardship in Human Healthcare in Post-Soviet States: A Systematic ReviewZhanar Kosherova, Kazakhstan |
| Clinical Infectious Diseases (Bacterial, Fungal, Mycobacterial, Parasitic) | |
| RES-217 | Weekly Antimicrobial Prophylaxis for Recurrent Symptomatic Urinary Tract Infections: A Randomized Controlled TrialParawee Maneejak, Thailand |
| RES-283 | Geographic Patterns of Nontuberculous Mycobacteria Diversity in Southeastern China: Insights from a Multiplex PCR-Based Surveillance StudyAijie Fang, China |
| Viral Infections & Immunology | |
| RES-292 | Estimating the Direct and Indirect Effects of Trust and Perceptions of SARS-CoV-2 Infection Risk on COVID-19 Re-vaccination Willingness in a Singapore CohortBrenda Ong, Singapore |
| RES-179 | The Interplay Between Social Behaviours and Acute COVID-19 Infection – Findings from a Longitudinal Cohort StudyLaysee Ong, Singapore |
| Healthcare Epidemiology & Infection Prevention/Control | |
| RES-041 | Aerosolised Methicillin-Resistant Staphylococcus Aureus (MRSA) Particles and their Role in Hospital Surface Contamination and Transmission Dynamics: An Interim AnalysisStephanie Sutjipto, Singapore |
| RES-061 | Pilot sStudy of Epidemiology of Coliform Bacteria in Different Area of Public Bathroom of Outpatient Department, Siriraj HospitalPeranut Korpraphong, Thailand |
| Emerging Topics & Others | |
| RES-107 | Impact of Ceftolozane/Tazobactam Initiation Timing on Hospitalization and Readmission Rates in Cystic Fibrosis Patients from the Study of Prescribing Patterns and Effectiveness of Ceftolozane/Tazobactam: Real-World Analysis (SPECTRA)Youngju Kim, United States |
| RES-252 | Gut Microbiome Restoration Through Phytocompounds: A Novel Approach to Treat Inflammatory Bowel DiseaseMd Mizanur Rahaman, Australia |
Exhibition
The exhibition brought together 35 companies showcasing the latest innovations in clinical microbiology and infectious diseases, providing a valuable networking platform.
Platinum Sponsors
Gold Sponsors
Silver Sponsors
Bronze Sponsors
Organized by:
Supporting Organizations:
Official Airline:
Future Events
